STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

Начало・Списък с акции・GlaxoSmithKline PLC

GlaxoSmithKline PLC

Затворен

СекторЗдравеопазване

1,846.25 0.29

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1841

Максимум

1869.25

Ключови измерители
By Trading Economics
Приходи	1.2B 1.8B
Продажби	-989M 7.6B
P/E Средно за сектора	13.387 49.8
EPS	0.465
Дивидентна доходност	3.47
Марж на печалбата	24.105
Служители	66,841
EBITDA	577M 2.8B

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+7.24% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	3.47% 2.25%
Следващи печалби	29.07.2026 г.
Следваща дата на дивидент	9.07.2026 г.
Следваща дата на екс-дивидент	14.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-4.2B 76B
Предишно отваряне	1845.96
Предишно затваряне	1846.25

Настроения в новините

By Acuity

56%

44%

271 / 347 Класиране в Healthcare

GlaxoSmithKline PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.04.2026 г., 06:42 ч. UTC

Печалби

GSK Earnings Boosted by Higher Specialty Medicine Sales

6.05.2026 г., 13:35 ч. UTC

Пазарно говорене

GSK Is Taking Steps in Right Direction, But Might Need More -- Market Talk

29.04.2026 г., 10:39 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

GSK CEO Sees RAPT Therapeutics Acquisition as Template for Future Deals -- Market Talk

29.04.2026 г., 10:06 ч. UTC

Пазарно говорене

Печалби

AstraZeneca, GSK Results Fail to Impress Market -- Market Talk

29.04.2026 г., 10:02 ч. UTC

Пазарно говорене

Печалби

GSK Makes Ideal Start for New CEO -- Market Talk

29.04.2026 г., 06:07 ч. UTC

Печалби

GSK PLC Sees 70p 2026 Dividend Payout

29.04.2026 г., 06:07 ч. UTC

Печалби

GSK PLC Declares Dividend of 17p

29.04.2026 г., 06:07 ч. UTC

Печалби

GSK PLC Free Cash Flow of GBP0.8B

29.04.2026 г., 06:06 ч. UTC

Печалби

GSK PLC Cash Generated From Operations GBP1.4B

29.04.2026 г., 06:06 ч. UTC

Печалби

GSK PLC 1Q General Medicines Sales GBP2.3B

29.04.2026 г., 06:06 ч. UTC

Печалби

GSK PLC 1Q Vaccines Sales GBP2.1B

29.04.2026 г., 06:06 ч. UTC

Печалби

GSK PLC 1Q Specialty Medicines Sales GBP3.2B

29.04.2026 г., 06:05 ч. UTC

Печалби

Analysts Saw GSK PLC 1Q Net Profit at GBP1.74B

29.04.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw GSK 1Q Adjusted Operating Profit of GBP2.46B

29.04.2026 г., 06:04 ч. UTC

Печалби

GSK PLC 1Q Adjusted Operating Profit GBP2.65B

29.04.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw GSK PLC Core EPS of 43.3p

29.04.2026 г., 06:04 ч. UTC

Печалби

Analysts Saw GSK PLC 1Q Turnover at GBP7.58B

29.04.2026 г., 06:04 ч. UTC

Печалби

GSK PLC 1Q Adj EPS 46.50p

29.04.2026 г., 06:01 ч. UTC

Печалби

GSK PLC Sees 2026 Adjusted EPS Growth of 7%-9%

29.04.2026 г., 06:01 ч. UTC

Печалби

GSK PLC Sees 2026 Adjusted Oper Pft Growth of 7%-9%

29.04.2026 г., 06:01 ч. UTC

Печалби

GSK PLC Sees 2026 Turnover Growth of 3%-5%

29.04.2026 г., 06:01 ч. UTC

Печалби

GSK PLC Backs 2026 View

29.04.2026 г., 06:00 ч. UTC

Печалби

GSK PLC 1Q EPS 42.6p

29.04.2026 г., 06:00 ч. UTC

Печалби

GSK PLC 1Q Turnover GBP7.63B

29.04.2026 г., 06:00 ч. UTC

Печалби

GSK PLC 1Q Pretax Pft GBP2.14B

29.04.2026 г., 06:00 ч. UTC

Печалби

GSK PLC 1Q Oper Pft GBP2.29B

29.04.2026 г., 06:00 ч. UTC

Печалби

GSK PLC 1Q Net Pft GBP1.74B

15.04.2026 г., 06:12 ч. UTC

Придобивния, сливания и поглъщания

GSK Completes Acquisition of 35Pharma

10.04.2026 г., 10:43 ч. UTC

Пазарно говорене

GSK Could Report Weak General Medicines Results -- Market Talk

31.03.2026 г., 14:02 ч. UTC

Придобивния, сливания и поглъщания

Samsung Biologics Will Continue Supplying Products Previously Manufactured at Site to GSK Under Terms of Agreement

Сравнение с други в отрасъла

Ценова промяна

GlaxoSmithKline PLC Прогноза

Ценова цел

By TipRanks

7.24% нагоре

12-месечна прогноза

Среден 1,976.36 GBX 7.24%

Висок 2,630 GBX

Нисък 1,500 GBX

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за GlaxoSmithKline PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

13 ratings

Купи

Задържане

Продай

Според 13 анализатори, дали борсови рейтинги на GlaxoSmithKline PLC през последните 3 месеца.

Настроение

By Acuity

271 / 347 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.